Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Clinical Investigation 2022, Vol.132 (13)
Hauptverfasser:	Zhang, Haohai, Feng, Lili, de Andrade Mello, Paola, Mao, Changchuin, Near, Richard, Csizmadia, Eva, Chan, Leo Li-Ying, Enjyoji, Keiichi, Gao, Wenda, Zhao, Haitao, Robson, Simon C
Format:	Report
Sprache:	eng
Schlagworte:	Cancer Care and treatment Health aspects Immunotherapy Monoclonal antibodies Neovascularization Physiological aspects Suppressor cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!